Immune Responses to Two Dose Varivax +/- MMR-II
Clinical trial NCT00258726 · TERMINATED
Trial details
- NCT number
- NCT00258726
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-01
- Primary completion
- 2007-07-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.